Canada markets close in 3 hours 38 minutes

Actinogen Medical Limited (3AC.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.0185-0.0015 (-7.50%)
As of 08:05AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 44.31M
Enterprise Value 37.29M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)6.32
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.58

Trading Information

Stock Price History

Beta (5Y Monthly) 2.28
52-Week Change 3-16.05%
S&P500 52-Week Change 325.77%
52 Week High 30.0290
52 Week Low 30.0075
50-Day Moving Average 30.0182
200-Day Moving Average 30.0145

Share Statistics

Avg Vol (3 month) 33.33k
Avg Vol (10 day) 310
Shares Outstanding 52.33B
Implied Shares Outstanding 62.51B
Float 81.71B
% Held by Insiders 117.85%
% Held by Institutions 110.63%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Dec 03, 2013

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,281.93%

Management Effectiveness

Return on Assets (ttm)-59.24%
Return on Equity (ttm)-106.02%

Income Statement

Revenue (ttm)4.79M
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-9.50%
Gross Profit (ttm)N/A
EBITDA -14.82M
Net Income Avi to Common (ttm)-14.87M
Diluted EPS (ttm)-0.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.47M
Total Cash Per Share (mrq)0
Total Debt (mrq)44.63k
Total Debt/Equity (mrq)0.37%
Current Ratio (mrq)5.42
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-12.53M
Levered Free Cash Flow (ttm)-7.09M